A bacterial enzyme boosts cell energy in aging animals

Mitochondria produce ATP, the fuel cells run on. As a side effect, this process generates reactive oxygen species (free radicals). In youth, cells handle these well. With age, the balance shifts and damage accumulates.

Researchers introduced a bacterial enzyme called LplA into worms and mice through gene therapy. LplA performs a chemical modification known as lipoylation: it attaches lipoic acid to proteins that regulate metabolism. Bacteria do this with a single enzyme; mammals need several, making the process less efficient. The researchers reported that treated animals moved better early in life and showed slower age-related decline later on, with results published in Science Advances.

Less damage, more output

In treated animals, lipoylation of key metabolic proteins increased while free radical levels dropped. The combination improved metabolism while reducing oxidative damage. That is a dual benefit that the researchers describe as combining vitality and longevity in a single intervention.

The caveats are significant. These are animal studies, not human trials. Introducing a bacterial protein into a mammal raises real concerns about immune reactions. The researchers acknowledge that the bar for human application is high: compelling evidence would be needed that the immune system tolerates the enzyme without adverse effects.

Why lipoylation matters for aging research

Lipoylation has mostly been studied in the context of diseases where the process is deficient. This research asks a different question: can enhancing lipoylation in otherwise healthy, aging cells slow the decline? In animal models, the answer appears to be yes, at least in part.

From a longevity perspective, the mechanism is broadly relevant: it targets a fundamental metabolic process conserved across virtually all living organisms, not just a single disease pathway.

Read the original article